Strategic Partnerships NVision emphasizes collaboration with surgeon thought leaders, researchers, and development engineers from prestigious institutions, plus key supporting partnerships to provide a complete array of device and biologic technologies. This suggests strong opportunities to engage distributors and hospital networks by offering integrated solutions and co-development initiatives.

Clinical Innovation With a history of launching 3D printed titanium wedges and implants, additive manufacturing capability, and FDA submission activity, there is a clear focus on innovative, surgeon-driven products. Sales outreach can highlight advanced materials and customization capabilities to target high-end orthopedic centers and specialty clinics.

Market Expansion Recent press indicates product launches across foot and ankle applications and collaboration with industry partners, signaling potential entry points in reconstructive foot and ankle markets and expanding geographic or channel reach through Lapidus International and similar networks.

SMB Growth Focus Company size (11–50 employees) and revenue in the low millions position NVISION as a lean, growth-oriented partner. This presents opportunities for high-touch, efficient sales motions, bundled offerings, and pilot programs with regional distributors and ambulatory surgical centers.

Strategic Fit Operating in medical devices and biologics with a San Antonio base and established partnerships, NVISION aligns with large players’ supply chains while maintaining agility. Target collaborations with mid-market hospital systems and specialty distributors seeking innovative, integrated device-biologic solutions and rapid product onboarding.